Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2012

Mar 20, 2012

30071_dirs_2012-03-20_5808e3c7-d0d0-4559-a059-b2bb1896ed22.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-03-12

Reporting Person: Relser Anne (President - ResMed Europe)

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 3148.705 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Non-Qualified Stock Options $20.3550 2016-02-23 ResMed Common Stock (6400) Direct
Non-Qualified Stock Options $24.57 2013-11-24 ResMed Common Stock (10000) Direct
Non-Qualified Stock Options $22.535 2014-11-27 ResMed Common Stock (30000) Direct
Non-Qualified Stock Options $20.80 2015-02-26 ResMed Common Stock (10000) Direct
Non-Qualified Stock Options $17.30 2015-11-24 ResMed Common Stock (34000) Direct
Restricted Stock Units $0 ResMed Common Stock (10286) Direct
Restricted Stock Units $0 ResMed Common Stock (5429) Direct
Restricted Stock Units $0 ResMed Common Stock (5429) Direct

Footnotes

F1: Restricted Stock Units do not have an expiration date.